MED18 Antikörper (AA 31-130) (Cy3)
Kurzübersicht für MED18 Antikörper (AA 31-130) (Cy3) (ABIN6983573)
Target
Alle MED18 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 31-130
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Homologie
- Dog,Cow,Sheep,Pig,Horse,Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human MED18
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- MED18 (Mediator Complex Subunit 18 (MED18))
-
Andere Bezeichnung
- MED18
-
Hintergrund
-
Synonyms: FLJ20045, hMED 18, hMED18, Human Mediator of RNA Polymerase II Transcription, MED 18, med18, MED18_HUMAN, Mediator complex subunit 18, Mediator of RNA polymerase II transcription subunit 18, Mediator of RNA polymerase II transcription subunit 18 homolog, OTTHUMP00000003645, p28b, TRAP/mediator complex subunit p28b.
Background: MED18 is a component of the Mediator complex, which is a coactivator for DNA-binding factors that activate transcription via RNA polymerase II (Sato et al., 2003 [PubMed 12584197]).[supplied by OMIM, Oct 2008]
-
Gen-ID
- 54797
-
UniProt
- Q9BUE0
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha
Target
-